You do not currently have access to this content.
Cancer Res (2026) 86 (5_Supplement_2): A010.
Search for other works by this author on: ...
1Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, United Kingdom. 2Advanced Immunotherapy and Cell Therapy Team, Department of Medical ...
Cancer Res (2025) 85 (8_Supplement_2): CT112.
Abstract. Molecular glue degrader (MGD) is an emerging therapeutic strategy offering an exciting alternative to traditional small molecules exploring new target space. These small molecules interact ...
Rongchang Pharmaceuticals, Ltd., Shanghai, China.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results